Gilead, Cipla Ink Deal To End HIV Drug Buyers' Antitrust Suit

[Gunnar Larson]

Gilead, Cipla Ink Deal To End HIV Drug Buyers' Antitrust Suit
<https://www.law360.com/competition/articles/1808926?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-03-04&read_main=1&nlsidx=0&nlaidx=7>

By Gina Kim

Gilead Sciences Inc. and generics maker Cipla told a California federal
judge Friday they've reached a settlement ending a proposed class action
filed by a public employees' health insurance fund over an alleged
anti-competitive patent deal to delay the launch of a generic version of
the HIV drug Truvada.

 1 document attached | Read full article »
<https://www.law360.com/competition/articles/1808926?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-03-04&read_more=1&nlsidx=0&nlaidx=7>
 | Save to favorites »
<https://www.law360.com/competition/articles/1808926?nl_pk=6416fd97-1dc4-4e02-b7d8-a89ca44ecaf4&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2024-03-04&read_later=1&nlsidx=0&nlaidx=7>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: text/html
Size: 2271 bytes
Desc: not available
URL: <https://lists.cpunks.org/pipermail/cypherpunks/attachments/20240304/c9aa532b/attachment.txt>